1nma Citations

N9 neuraminidase complexes with antibodies NC41 and NC10: empirical free energy calculations capture specificity trends observed with mutant binding data.

Biochemistry 33 7986-97 (1994)
Cited: 27 times
EuropePMC logo PMID: 7517697

Abstract

X-ray crystallographic coordinates of influenza virus N9 neuraminidase complexed with monoclonal antibodies NC41 and NC10 [Tulip et al. (1992) J. Mol. Biol. 227, 122-148] served as a starting point for calculations aimed at estimating free energy changes (delta G) of complex formation between the two antibodies and the neuraminidase. Using an empirical function incorporating hydrophobic, electrostatic, and conformational entropy effects, we estimated contributions individual neuraminidase residues make to complex formation (delta G(residue)) and compared the calculated values to experimentally measured differences in antibody binding between the wild-type and mutated neuraminidases [Nuss et al. (1993) Proteins 15, 121-132; calculations done without prior knowledge of the experimental data]. A good correspondence was found between the calculated delta G(residue) values and the mutant binding data in that side chains with large calculated delta G contributions (delta G(residue) < -1 kcal/mol) lie at sites of mutation which cause a marked reduction in antibody binding, and side chains for which delta G(residue) > -1 kcal/mol are sites at which a mutation does not have a marked effect on binding. Because most of the delta G(residue) < -1 kcal/mol side chains also make hydrogen bonds/salt bridges with the antibody, the correspondence of the effect of antibody binding with these electrostatic interactions (18 out of 27 for NC41 and, tentatively, 5 out of 7 for NC10) is about as good as that with predicted energetic residues. All the delta G(residue) < -1 kcal/mol neuraminidase side chains cluster around the most protruding surface regions and are thus spread over different epitope segments. Surprisingly, different residues were found to make the most critical contributions to the NC41 and NC10 complex stabilities despite the fact that the NC41 and NC10 antigenic epitopes overlap, having approximately 70% of surface residues in common. It is thus possible, for two different antibodies, to recognize the same protein surface in strikingly different ways. As only a fraction of the neuraminidase residues appear to make large contributions to antibody binding, the results also support the hypothesis of a "functional" epitope in antigen-antibody interactions. Positive trends between both backbone rigidity and residue accessibility in the complexed state, and contributions of these residues to binding, were also observed for the NC41 complex.

Articles - 1nma mentioned but not cited (4)

  1. Structure of influenza virus N7: the last piece of the neuraminidase "jigsaw" puzzle. Sun X, Li Q, Wu Y, Wang M, Liu Y, Qi J, Vavricka CJ, Gao GF. J. Virol. 88 9197-9207 (2014)
  2. A relation between the principal axes of inertia and ligand binding. Foote J, Raman A. Proc. Natl. Acad. Sci. U.S.A. 97 978-983 (2000)
  3. Functional Versatility of AGY Serine Codons in Immunoglobulin Variable Region Genes. Detanico T, Phillips M, Wysocki LJ. Front Immunol 7 525 (2016)
  4. Molecular-level simulation of pandemic influenza glycoproteins. Amaro RE, Li WW. Methods Mol. Biol. 819 575-594 (2012)


Reviews citing this publication (4)

  1. Prediction of the binding energy for small molecules, peptides and proteins. Schapira M, Totrov M, Abagyan R. J. Mol. Recognit. 12 177-190 (1999)
  2. Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Braden BC, Goldman ER, Mariuzza RA, Poljak RJ. Immunol. Rev. 163 45-57 (1998)
  3. Modeling protein-ligand complexes. Bamborough P, Cohen FE. Curr. Opin. Struct. Biol. 6 236-241 (1996)
  4. Virus versus antibody. Colman PM. Structure 5 591-593 (1997)

Articles citing this publication (19)

  1. A hot spot of binding energy in a hormone-receptor interface. Clackson T, Wells JA. Science 267 383-386 (1995)
  2. Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. Clackson T, Ultsch MH, Wells JA, de Vos AM. J. Mol. Biol. 277 1111-1128 (1998)
  3. Electrostatic complementarity at protein/protein interfaces. McCoy AJ, Chandana Epa V, Colman PM. J. Mol. Biol. 268 570-584 (1997)
  4. A physical reference state unifies the structure-derived potential of mean force for protein folding and binding. Liu S, Zhang C, Zhou H, Zhou Y. Proteins 56 93-101 (2004)
  5. Potential of mean force for protein-protein interaction studies. Jiang L, Gao Y, Mao F, Liu Z, Lai L. Proteins 46 190-196 (2002)
  6. Analysis of protein-protein interactions and the effects of amino acid mutations on their energetics. The importance of water molecules in the binding epitope. Covell DG, Wallqvist A. J. Mol. Biol. 269 281-297 (1997)
  7. Empirical free energy calculations: a blind test and further improvements to the method. Novotny J, Bruccoleri RE, Davis M, Sharp KA. J. Mol. Biol. 268 401-411 (1997)
  8. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis. Kortt AA, Nice E, Gruen LC. Anal. Biochem. 273 133-141 (1999)
  9. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. Venkatramani L, Bochkareva E, Lee JT, Gulati U, Graeme Laver W, Bochkarev A, Air GM. J. Mol. Biol. 356 651-663 (2006)
  10. The 2.5 A resolution structure of the jel42 Fab fragment/HPr complex. Prasad L, Waygood EB, Lee JS, Delbaere LT. J. Mol. Biol. 280 829-845 (1998)
  11. Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin. Cherry JL, Lipman DJ, Nikolskaya A, Wolf YI. PLoS Curr 1 RRN1001 (2009)
  12. Antibody BCF2 against scorpion toxin Cn2 from Centuroides noxius Hoffmann: primary structure and three-dimensional model as free Fv fragment and complexed with its antigen. Selisko B, Licea AF, Becerril B, Zamudio F, Possani LD, Horjales E. Proteins 37 130-143 (1999)
  13. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10. Lee JT, Air GM. Virology 300 255-268 (2002)
  14. Determination of the binding constants for three HPr-specific monoclonal antibodies and their Fab fragments. Smallshaw JE, Brokx S, Lee JS, Waygood EB. J. Mol. Biol. 280 765-774 (1998)
  15. Grafting of protein-protein interaction epitope. Liang S, Li W, Xiao L, Wang J, Lai L. J. Biomol. Struct. Dyn. 17 821-828 (2000)
  16. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection. Wan H, Qi L, Gao J, Couzens LK, Jiang L, Gao Y, Sheng ZM, Fong S, Hahn M, Khurana S, Taubenberger JK, Eichelberger MC. J. Virol. 92 (2018)
  17. Structural modeling of the complex between an acetylcholine receptor-mimicking antibody and its snake toxin antigen. Tenette-Souaille C, Smith JC. Proteins 30 249-263 (1998)
  18. Structure of the Malpha2-3 toxin alpha antibody-antigen complex: combination of modelling with functional mapping experimental results. Tenette-Souaille C, Smith JC. Protein Eng. 13 345-351 (2000)
  19. Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase. Lei R, Kim W, Lv H, Mou Z, Scherm MJ, Schmitz AJ, Turner JS, Tan TJC, Wang Y, Ouyang WO, Liang W, Rivera-Cardona J, Teo C, Graham CS, Brooke CB, Presti RM, Mok CKP, Krammer F, Dai X, Ellebedy AH, Wu NC. Immunity 56 2621-2634.e6 (2023)


Related citations provided by authors (3)

  1. Refined Crystal Structures of the Influenza Virus N9 Neuraminidase-Nc41 Fab Complex. Tulip WR, Varghese JN, Laver WG, Webster RG, Colman PM J. Mol. Biol. 227 122- (1992)
  2. Three Dimensional Structures of Influenza Virus Neuraminidase-Antibody Complexes. Colman PM, Tulip WR, Varghese JN, Tulloch PA, Baker AT, Laver WG, Air GM, Webster RG Philos. Trans. R. Soc. London,Ser. B 323 511- (1989)
  3. Crystal structures of neuraminidase-antibody complexes.. Tulip WR, Varghese JN, Webster RG, Air GM, Laver WG, Colman PM Cold Spring Harb Symp Quant Biol 54 Pt 1 257-63 (1989)